Experimental Medication For the Treatment of Generalized Anxiety Disorder
NCT ID: NCT00097708
Last Updated: 2014-10-03
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
511 participants
INTERVENTIONAL
2004-11-30
2005-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy, Safety and Tolerability of XBD173 in Patients With Generalized Anxiety Disorder
NCT00108836
A Long-Term Study Continuing on From Study 04-001-01 of an Experimental Medication in Adults With Anxiety Disorder
NCT00106860
A Study to Assess the Efficacy and Safety of CD-008-0045 in Patients With Generalized Anxiety Disorder
NCT04598867
Treatment of Patients With Anxiety Disorder (0777-022)
NCT00539578
EDG004 Treatment of Adult Patients With Generalized Anxiety Disorder (GAD)
NCT02305797
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The primary objective of the study is to assess, under controlled conditions, the safety and efficacy of an experimental anti-anxiety medication relative to placebo in subjects with generalized anxiety disorder (GAD).
The secondary objective of the study is to study algorithms for discontinuation of an experimental anti-anxiety medication.
Recruiting: Participants are currently being recruited and enrolled.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
experimental anti-anxiety drug
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Jazz Pharmaceuticals
INDUSTRY
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Murray Stein, MD
Role: STUDY_CHAIR
University of California, San Diego
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Birmingham Research Group, Inc.
Birmingham, Alabama, United States
Crest Clinical Trials, Inc.
Anaheim, California, United States
Southwesten Research, Inc.
Beverly Hills, California, United States
Southwestern Research Institute
Burbank, California, United States
University of California - San Diego - Dept of Psychiatry
San Diego, California, United States
Clinical Innovations
Santa Ana, California, United States
Stanford University Medical Center
Stanford, California, United States
Diablo Clinical Research, Inc.
Walnut Creek, California, United States
Alpine Clinical Research Center
Boulder, Colorado, United States
New Britain General Hospital
New Britain, Connecticut, United States
Florida Clinical Research Center
Bradenton, Florida, United States
ACT Clinical Research
DeLand, Florida, United States
University Clinical Research DeLand, Inc.
DeLand, Florida, United States
Sarkis Clinical Trials
Gainsville, Florida, United States
Clinical Neuroscience Solutions, Inc.
Jacksonville, Florida, United States
Clinical Neuroscience Solutions, Inc.
Orlando, Florida, United States
Meridien Research
St. Petersburg, Florida, United States
Institute of Research in Psychiatry
Tampa, Florida, United States
Janus Center for Psychiatric Research
West Palm Beach, Florida, United States
Atlanta Institute of Medicine and Research
Marietta, Georgia, United States
Radiant Research
Boise, Idaho, United States
American Medical Research, Inc.
Oak Brook, Illinois, United States
Peak Medical Research, LLC
Owensboro, Kentucky, United States
New Orlean Medical Institute
Metairie, Louisiana, United States
Brentwood Research Institute
Shreveport, Louisiana, United States
Pharmasite Research, Inc.
Baltimore, Maryland, United States
McLean Hospital
Belmont, Massachusetts, United States
Pivotal Research Centers - Detroit
Royal Oak, Michigan, United States
MedClin Research
St Louis, Missouri, United States
CNS Research Institute (CRI)
Clementon, New Jersey, United States
ClinSearch, Inc.
Kenilworth, New Jersey, United States
Princeton Medical Institute
Princeton, New Jersey, United States
Social Psychiatry Research Institute
Brooklyn, New York, United States
Midwest Clinical Research Center
Dayton, Ohio, United States
Neurology and Neuroscience Center of Ohio
Toledo, Ohio, United States
IPS Research Company
Oklahoma City, Oklahoma, United States
Laureate Psychiatric Clinic and Hospital
Tulsa, Oklahoma, United States
Oregon Center for Clinical Investigations, Inc.
Eugene, Oregon, United States
Suburban Research Associates
Media, Pennsylvania, United States
CNS Research Institute
Philadelphia, Pennsylvania, United States
Southeast Health Consultants, LLC
Charleston, South Carolina, United States
CNS, Inc.
Memphis, Tennessee, United States
Clinical Research Associates, Inc.
Nashville, Tennessee, United States
FutureSearch Trials
Austin, Texas, United States
Research Across America
Dallas, Texas, United States
R/D Clinical Research, Inc.
Lake Jackson, Texas, United States
Lifetree Clinical Research
Salt Lake City, Utah, United States
Comprehensive Neuroscience of Northern Virginia
Falls Church, Virginia, United States
Dominion Clinical Research, Inc.
Midlothian, Virginia, United States
Northwest Clinical Research Center
Bellevue, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
JZP 04-001-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.